BNAR syndrome
bee-nar sin-drohm
Also known as: Bifid Nose Renal Agenesis Anorectal malformations syndrome, FREM1-related condition
At a Glance
What is BNAR syndrome?
BNAR syndrome is a rare genetic disorder that primarily affects the development of the nose, kidneys, and anus. Individuals with this condition often have a bifid nose, which means the nose is split or divided. The syndrome can also lead to renal agenesis, where one or both kidneys fail to develop, and anorectal malformations, affecting the normal development of the anus. It is caused by mutations in the FREM1 gene, which plays a crucial role in the development of certain tissues during embryogenesis. Symptoms can vary widely, but early signs often include facial abnormalities and urinary tract issues. As the child grows, gastrointestinal problems may become more apparent due to anorectal malformations. Early diagnosis is critical to manage the symptoms effectively and improve quality of life. The condition can place a significant emotional and financial burden on families due to the need for ongoing medical care and interventions. Prognosis depends on the severity of the symptoms and the presence of associated anomalies. Daily life for affected individuals may involve regular medical check-ups, surgeries, and therapies to manage symptoms. Despite the challenges, with appropriate medical care, many individuals can lead fulfilling lives. Support from healthcare providers and patient organizations can be invaluable for families navigating this condition.
Medical Definition
BNAR syndrome is a genetic disorder characterized by bifid nose, renal agenesis, and anorectal malformations, resulting from mutations in the FREM1 gene. Pathologically, the syndrome involves disrupted extracellular matrix interactions crucial for normal embryonic development. Histological findings may reveal abnormal tissue organization in affected organs. It is classified under autosomal recessive genetic disorders, with a very low prevalence, making it a rare condition. The disease course can vary, with some individuals experiencing severe complications while others have milder symptoms. Early intervention and multidisciplinary care are essential for managing the diverse manifestations of the syndrome.
BNAR syndrome Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Bifid nose manifests as a visible cleft or separation in the nasal structure. This occurs due to disruptions in the normal fusion of nasal processes during embryonic development, often linked to mutations in the FREM1 gene. Over time, the bifid nose may become more pronounced as facial features mature. It can affect breathing and self-esteem, but surgical correction can improve both function and appearance.
Renal agenesis is characterized by the absence of one or both kidneys at birth. This results from a failure in the development of the ureteric bud, which is crucial for kidney formation, often due to genetic mutations in FREM1. If unilateral, it may go unnoticed until later in life, but bilateral agenesis is life-threatening and requires immediate intervention. Daily life can be severely impacted by renal insufficiency, necessitating dialysis or transplantation.
Anorectal malformations present as abnormal development of the anus and rectum, leading to difficulties in bowel movements. These malformations arise from disrupted embryonic development of the hindgut, influenced by genetic factors such as FREM1 mutations. Over time, these malformations can lead to chronic constipation or incontinence if not corrected. Surgical intervention is often required to allow normal bowel function and improve quality of life.
Common
Congenital diaphragmatic hernia involves an abnormal opening in the diaphragm, allowing abdominal organs to move into the chest cavity. This defect is due to improper development of the diaphragm, potentially linked to FREM1 gene mutations. It can cause respiratory distress at birth and may require surgical repair. Early intervention is crucial to prevent long-term respiratory complications and improve survival rates.
Facial asymmetry is characterized by uneven features on either side of the face, often noticeable in the eyes, nose, or mouth. This can result from asymmetric growth or development of facial bones and tissues, possibly due to genetic mutations. As the individual grows, the asymmetry may become more apparent, affecting self-esteem and social interactions. Orthodontic or surgical treatments can help correct the asymmetry and improve facial harmony.
Hearing loss in BNAR syndrome can range from mild to severe and may affect one or both ears. It is often caused by structural abnormalities in the ear or nerve pathways, potentially linked to FREM1 mutations. Over time, untreated hearing loss can lead to speech and language delays, especially in children. Hearing aids or cochlear implants, along with speech therapy, can significantly enhance communication abilities.
Less Common
Cleft palate is a condition where there is an opening in the roof of the mouth due to incomplete fusion of tissues. This defect is often associated with genetic factors, including FREM1 mutations. If not corrected, it can lead to feeding difficulties, speech problems, and recurrent ear infections. Surgical repair is typically performed in infancy to restore normal function and appearance.
Skeletal abnormalities may include limb deformities or spine curvature, resulting from disrupted bone development. These abnormalities can be linked to genetic mutations affecting connective tissue integrity, such as those in FREM1. As the child grows, these issues may lead to mobility challenges or chronic pain. Orthopedic interventions and physical therapy can help manage symptoms and improve mobility.
What Causes BNAR syndrome?
BNAR syndrome is primarily caused by mutations in the FREM1 gene, located on chromosome 9p22.3. The FREM1 gene encodes a protein that is part of the extracellular matrix, which plays a crucial role in maintaining the structural integrity of tissues. Mutations in FREM1 can lead to misfolding or truncation of the protein, disrupting its ability to interact with other matrix components. This disruption affects cellular adhesion and signaling pathways, leading to impaired tissue development. The immediate molecular consequence is a loss of extracellular matrix stability, which compromises the structural support for developing organs. This instability can lead to organ malformations, particularly affecting the nose, kidneys, and anorectal region. Neuroinflammation may be triggered as the body attempts to respond to these developmental anomalies, potentially exacerbating tissue damage. In some cases, immune responses may further contribute to the degeneration of affected tissues, including white matter in the central nervous system. The specific pattern of symptoms, such as bifid nose and renal agenesis, arises from the critical roles FREM1 plays during embryonic development of these structures. Variability in disease severity among patients can be attributed to the type and location of the FREM1 mutation, as well as potential modifier genes and environmental factors. Additionally, the timing of expression and interaction with other developmental pathways can influence the phenotypic outcome. Some patients may exhibit isolated symptoms like bifid nose, while others present with a full spectrum of anomalies, reflecting the complex interplay of genetic and environmental influences. Understanding the precise molecular mechanisms continues to be a focus of research, with the goal of developing targeted therapies.
How is BNAR syndrome Diagnosed?
Typical age of diagnosis: BNAR syndrome is typically diagnosed in infancy or early childhood when characteristic physical anomalies become apparent. Diagnosis often occurs after parents or pediatricians notice unusual facial features or developmental issues.
Clinicians look for key features such as bifid nose, renal agenesis, and anorectal malformations. A detailed family history is important to identify any genetic predisposition. Physical examination focuses on identifying dysmorphic features and any associated anomalies. This step helps narrow down the differential diagnosis and guides further testing.
Ultrasound and MRI are commonly used imaging modalities. These studies can reveal renal agenesis and other structural abnormalities. Imaging findings help confirm the diagnosis by correlating clinical features with anatomical defects. They also help exclude other conditions with similar presentations, such as VACTERL association.
Blood tests may include renal function tests and electrolytes to assess kidney function. Abnormal results, such as elevated creatinine, suggest renal impairment. These results guide further management and the need for nephrology consultation. Laboratory tests also help monitor the progression of renal disease.
Genetic testing focuses on sequencing the FREM1 gene. Mutations such as missense, nonsense, or splice site variants are identified. Positive results confirm the diagnosis of BNAR syndrome and allow for precise genetic counseling. This information is crucial for family planning and assessing recurrence risk in future pregnancies.
BNAR syndrome Treatment Options
ACE inhibitors are used to manage hypertension and proteinuria in patients with renal involvement. They work by inhibiting the angiotensin-converting enzyme, reducing blood pressure, and protecting renal function. Common drugs include enalapril and lisinopril. Clinical evidence supports their efficacy in slowing the progression of renal disease. However, side effects such as hyperkalemia and cough may limit their use.
Techniques include motor skill exercises and sensory integration therapy. The goal is to improve physical coordination and cognitive development. Sessions are typically conducted weekly and last 30-60 minutes. Outcomes are measured by developmental milestones and functional improvements. Long-term benefits include enhanced quality of life and independence.
Surgery is indicated for correcting bifid nose and anorectal malformations. The procedure involves reshaping nasal cartilage and reconstructing the anorectal region. Expected benefits include improved appearance and bowel function. Surgical risks include infection and anesthesia complications. Post-operative care involves monitoring for complications and ensuring proper wound healing.
The care team includes geneticists, nephrologists, surgeons, and therapists. Interventions focus on managing symptoms, monitoring growth, and addressing developmental delays. Psychosocial support includes counseling and support groups for families. Education is provided on disease management and potential complications. Long-term monitoring involves regular follow-ups to assess health status and adjust care plans.
When to See a Doctor for BNAR syndrome
- Severe breathing difficulties — this is an emergency because it may indicate a congenital diaphragmatic hernia, which requires immediate medical intervention.
- Acute abdominal pain — this could signal an anorectal malformation or obstruction, necessitating urgent evaluation.
- Signs of renal failure such as decreased urine output — this is critical as it may indicate renal agenesis, which can lead to life-threatening complications.
- Recurrent urinary tract infections — these may suggest underlying renal anomalies and should be evaluated by a healthcare provider.
- Persistent constipation — this could be a sign of an anorectal malformation and warrants further investigation.
- Unusual facial features such as a bifid nose — while not immediately dangerous, these may be indicative of BNAR syndrome and should prompt genetic consultation.
- Mild nasal congestion — monitor for any changes or worsening, as it may be related to nasal structural anomalies.
- Occasional mild abdominal discomfort — keep track of frequency and triggers, and consult a doctor if it becomes more frequent or severe.
BNAR syndrome — Frequently Asked Questions
Is this condition hereditary?
BNAR syndrome is inherited in an autosomal recessive pattern, meaning both parents must carry a copy of the mutated gene. The probability of passing the condition to children is 25% if both parents are carriers. De novo mutations are not typically associated with BNAR syndrome. Carrier status can have implications for family planning, and genetic counseling is recommended to understand risks and options. Genetic testing can confirm carrier status and help guide family planning decisions.
What is the life expectancy for someone with this condition?
Life expectancy can vary significantly depending on the severity of associated anomalies like renal agenesis and diaphragmatic hernia. Early diagnosis and intervention can improve outcomes, while severe organ malformations may worsen prognosis. Mortality is often related to complications from renal failure or respiratory issues. Treatment such as surgical correction of malformations can enhance survival and quality of life. Realistic expectations should be discussed with a healthcare provider, considering individual health status and available treatments.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis typically involves genetic testing to identify FREM1 mutations, often following clinical suspicion based on symptoms. The time from first symptoms to diagnosis can vary, but it may take several months due to the rarity of the condition. Specialists such as geneticists, nephrologists, and pediatric surgeons are often consulted. Delayed diagnosis can occur due to the variability of symptoms and lack of awareness. Confirmation is achieved through genetic testing and clinical evaluation of symptoms.
Are there any new treatments or clinical trials available?
Current research is exploring gene therapy and novel approaches to manage symptoms and improve quality of life. ClinicalTrials.gov is a resource for finding ongoing trials related to BNAR syndrome and related conditions. Discussing potential participation in trials with your doctor is advisable to understand risks and benefits. New treatments are being developed, but timelines for availability can vary. Staying informed through medical updates and support groups can provide the latest information.
How does this condition affect daily life and activities?
BNAR syndrome can impact mobility and self-care, particularly if physical anomalies are present. Educational support may be needed due to potential developmental delays. Social and emotional challenges can arise from visible differences and health-related restrictions. The condition can place a significant burden on families, requiring medical and emotional support. Adaptations such as physical therapy and counseling can help manage daily challenges and improve quality of life.
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.FREM1 Autosomal Recessive Disorders.
Adam MP, Bick S, Mirzaa GM et al. · Unknown Journal · 1993 · PMID: 20301721
- 2.Bifid nose as the sole manifestation of BNAR syndrome, a FREM1-related condition.
Brischoux-Boucher E, Dahlen E, Gronier C et al. · Clin Genet · 2020 · PMID: 32926405
- 3.Novel FREM1 mutations expand the phenotypic spectrum associated with Manitoba-oculo-tricho-anal (MOTA) syndrome and bifid nose renal agenesis anorectal malformations (BNAR) syndrome.
Nathanson J, Swarr DT, Singer A et al. · Am J Med Genet A · 2013 · PMID: 23401257
- 4.Manitoba-oculo-tricho-anal (MOTA) syndrome is caused by mutations in FREM1.
Slavotinek AM, Baranzini SE, Schanze D et al. · J Med Genet · 2011 · PMID: 21507892
- 5.A novel homozygous splicing variant in FREM1 expands the phenotypic spectrum of BNAR syndrome: functional validation and successful PGT-M.
Yan L, Liu Y, Zhang Y et al. · BMC Med Genomics · 2026 · PMID: 41923049
- 6.Deficiency of FRAS1-related extracellular matrix 1 (FREM1) causes congenital diaphragmatic hernia in humans and mice.
Beck TF, Veenma D, Shchelochkov OA et al. · Hum Mol Genet · 2013 · PMID: 23221805
- 7.Non-Canonical Splice Site Variant in FREM1 Result in Fetal Renal Agenesis.
Feng X, Hu Y, Wang X et al. · Clin Genet · 2026 · PMID: 40605465
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-04-28